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Microorganisms are able to respond effectively to diverse signals from their environment and internal
metabolism owing to their inherent sophisticated information processing capacity. A central aim of
synthetic biology is to control and reprogramme the signal processing pathways within living cells so as
to realise repurposed, beneficial applications ranging from disease diagnosis and environmental sensing
to chemical bioproduction. To date most examples of synthetic biological signal processing have been
built based on digital information flow, though analogue computing is being developed to cope with
more complex operations and larger sets of variables. Great progress has been made in expanding the
categories of characterised biological components that can be used for cellular signal manipulation,
thereby allowing synthetic biologists to more rationally programme increasingly complex behaviours
into living cells. Here we present a current overview of the components and strategies that exist for
designer cell signal processing and decision making, discuss how these have been implemented in
prototype systems for therapeutic, environmental, and industrial biotechnological applications, and
examine emerging challenges in this promising field.
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eviewIntroduction – biological signal processing
Signal processing circuits are widely used in electronic systems to
modulate the electrical signal flows necessary to achieve particular
desired applications. Similarly, cells employ sophisticated gene
regulatory networks to continuously process biological signals for
their survival and reproduction [1]. Microorganisms possess the
capabilities to sense a myriad of signals, but to coordinate an
appropriate response this information must be processed: various
types of signal must be transformed to enable interaction between
data flows; crosstalk must be prevented between some, whilst
others need to be composed to allow combination or comparison;
digital and analogue behaviour from different processing units
may require assimilation (Fig. 1a). These concerns are central to
the goals of synthetic biologists: signal processing behaviour
defines the function of the system, so rational design of a
biological system is the ability to predictably coordinate the
interactions between, and conversion of, various input signals.
The term ‘synthetic biology’ broadly describes the development of
tools and techniques that facilitate the rational design and con-
struction of new biological devices and systems for use in biotech-
nological applications (and arguably also facilitate basic research)
[2–4], hence the motivation for examining how designer cellular
signal processing has been used to build prototype biotechnologi-
cal applications.
Signal processing arises from the characteristics of the interac-
tions (abstracted to ‘transfer functions’) between information
carriers: activation of transcription by regulators [5], small-
RNA-mediated translation inhibition [6], protein–protein inter-
action [7], etc. Reasonably accurate design of biological informa-
tion processing networks therefore depends on knowledge of the
kinetic parameters of these interactions, a task that is being made
easier through the development of part libraries [6,8]. Incomplete
understanding of how parts interact with each other and their
genetic, cellular, and environmental contexts [9] limits the extent
to which behaviour can be predicted. Minimising or removing
interactions between the designer circuit and its cellular context
often aids performance, but the ability to tune elements (an
activity facilitated by having parts that are easily exchangeable)
is often required to enable refinement of the system.
Digital and analogue biological information processing
Biological systems are inherently analogue; though the physical
state of cellular components could be considered to encode digital
information, their interactions (the basis of computation) are
based on probability [10], leading to graded responses at the level
of a population of biomolecules or cells. Analogue signal proces-
sing uses the characteristics of these graded responses as the basis
for computing, for example, two positive log-linear inputs that
stimulate the same log-linear output are summed [11]. Digital
characteristics are a special case of the standard analogue behav-
iour, where the transition between distinct low and high levels
of the output occurs over a relatively narrow range of input.
Components which exhibit digital behaviour can be combined
to produce Boolean logic-based decision circuits (Fig. 1b)
[1,8,12,13]. There are pronounced energetic and orthogonal part
limitations on digital systems when scaling-up biological comput-
ing. Whilst efforts in synthetic biology have thus far tended to
emulate the digital paradigm of electronic engineering, future636 www.elsevier.com/locate/nbtadvances in the complexity of synthetic biological systems are
likely to require more analogue-based computing (Fig. 1c) [10,11].
Nonetheless, small-scale logic circuits are tractable and well suited
to a range of applications, such as threshold detection [14] and
environmental sensing [5].
Effective digital cellular signal processing results in a single
output changing between distinct OFF and ON (low/high) states
in response to one or more input signals. Better digital signal
fidelity exists in signals with lower noise (e.g. higher concentration
of participating molecules [15]), and larger ON:OFF ratios, that can
be produced by lowering the level of the output in the OFF state,
for example, by reducing leaky transcription at a promoter [16], or
raising the level of the ON state, for example, through increasing
translation rates by using a stronger RBS [17]. The change in output
state must switch sharply as the input crosses a defined threshold
level to avoid ambiguity. Input–output functions that have Hill
coefficients greater than one generally show this behaviour, as do
those which receive positive feedback from the output [18,19]. A
major concern when designing digital-based circuits is matching
the input and output thresholds of linked components so that
downstream components are activated appropriately [20].
The transfer functions of analogue genetic signal processing
ideally have well-defined response curves that operate (i.e. remain
unsaturated) over a wide dynamic range of input [11] and exhibit
low noise. The dynamic range of analogue functions can be
extended by introducing a negative feedback loop [11,21] or by
attenuating the gain in the transfer function [22].
Strategies for designer cell signal processing
The components and mechanisms of decision gene circuits can
be as varied as the biochemical basis of the organism itself.
Whilst many examples use the regulation of gene expression
as the basis for information flow, data can be carried by all
biological molecules, from nucleic acids to proteins to metabo-
lites. Not all signal types are composable, however, and signal
processing circuits generally transform diverse inputs into a
common medium for computation. Below we summarise and
provide our own perspectives on the range of strategies and
tools available for performing various types of signal processing
in synthetic biological systems.
Transcriptional control
Transcriptional repressors and activators bind to operator
sequences in DNA and respectively inhibit and enhance the tran-
scription of genes by RNA polymerase, thus increasing or decreas-
ing output signal flux. The transcription rate can be controlled by
varying the concentration of regulator. For example, the Pseudo-
monas syringae HrpRS-V system tightly regulates expression from
the s54-dependent PhrpL promoter [5,23], making analogue signal
modulation possible through graded expression of either activator
(positive response), or the HrpS-sequestering HrpV inhibitor (neg-
ative response) (Fig. 1c) [22]. The close-to-zero transcriptional
output in the OFF state makes the three HrpRS-V inputs ideally
suited to building effective digital logic circuits with up to three
inputs (Fig. 1b) [7]. A network of three orthogonal repressor-
promoter pairs was used to build the classic ‘repressilator’ [24],
but larger biological signal processing systems require more com-
ponents: a library of regulators based on TetR homologues was
New Biotechnology Volume 32, Number 6 December 2015 REVIEW
FIGURE 1
Digital and analogue signal processing in cells. (a) Two modes of cell signal processing exist in biological systems: digital logic, where signal output switches rapidly
between low ‘OFF’ and high ‘ON’ states, and analogue responses which are graded transformations of the input signal. Combination and mixing of digital and
analogue processing of transduced sensor signals can be useful to drive various customised cellular responses. (b) The digital logic mode is exemplified by a
combinatorial genetic NAND gate in which the output is only off when both of the two input small molecules (I1, I2) signals are present [5]. Expression of both HrpR and
HrpS is required to activate expression of the cI repressor, which blocks transcription of the gfp output gene. (c) The analogue mode is exemplified by a gain-tunable
transcriptional amplifier in which the analogue nature of two inputs is combined to control an analogue output [22]. The device functions such that the weak
transcriptional input signal (I) scales linearly in response to a second ‘gain tuning’ transcriptional input (bT). (d) Signals can be stored as digital memory elements. The
constitutive promoter Pconst is flanked by serine integrase attB and attP sites, oriented such that the action of the integrase (INT) flips the memory element (denoted
between dashed lines), forming attL and attR sites [51]. Co-expression of the excisionase (EX) partner biases the integrase action in the reverse direction. Pconst drives
transcription of GFP and RFP genes outside of the memory element to report its state.
www.elsevier.com/locate/nbt 637
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orthogonal repressor-operator pairs [8]. Sets of repressors and
activators that target a specific desired regulatory sequence can
also be produced through fusions with artificial zinc-finger [25]
and transcription activator-like effector (TALE) [26] proteins. Al-
ternatively, the regulator’s DNA binding affinity/specificity can be
altered by association with a ligand molecule; in these cases the
concentration of both regulator protein and ligand may be con-
sidered inputs. In addition to classical examples of inducible
promoters controlled by regulators that bind metabolites (e.g.
LacI, AraC), signalling molecules (e.g. LuxR), and metal ions
(e.g. ArsR), more recent CRISPR (clustered regularly interspaced
short palindromic repeats)-based tools which require binding of
guide RNA (gRNA) sequences have been developed. Nuclease-
inactive Cas9 protein can function as a repressor that works by
steric hindrance of RNAP at the promoter [27,28], or Cas9 can
also be fused with other repressors or activators. Synthetic pro-
moters and genes can be designed to contain multiple different
regulator binding sites in order to increase the number of inputs
that control the transcriptional output [8].
The rate of RNA production from a gene can also be regulated by
the supply or binding kinetics of the polymerase enzyme: use of
the phage T7 RNAP allows the activity of transcription itself to be
orthogonal to the host transcriptional machinery; part-mining
by Temme et al. (2012) produced four variants of T7 RNAP that
recognise unique targets [29]. It has also been shown that split T7
polymerase fragments can reassemble into a functional enzyme
in vivo, allowing new orthogonal logic gates to be built based on
the differential expression of individual functional fragments [30].
Another different approach to transcriptional control was taken
by Rhodius et al. (2013), who constructed a library of orthogonal
bacterial RNAP sigma factors – proteins that determine promoter
sequence recognition by RNAP – and their cognate promoter
sequences to enable the modulation of RNAP binding kinetics [31].
Control of RNA stability
Targeted degradation of mRNA can be used to attenuate a signal,
with strategies such as small RNA-mediated Hfq protein recruit-
ment [32] and RNA interference [12] both requiring the input of
small non-coding RNAs [33,34]. Cys4-based RNA cleavage has
been shown to be an effective regulator of signal strength that
works well in different sequence contexts [35]: incorporation of
the cleavage targeting sequence into a synthetic RNA allows either
processing of RNAs for more efficient expression or disruption of
coding sequences to prevent translation.
Control of translation
Many classes of RNA can act to prevent translation of an mRNA
molecule: RNA-IN–RNA-OUT translation inhibition occurs
through the binding of the short non-coding RNA-OUT molecule
to the corresponding RNA-IN sequence located at the translation
initiation region of an mRNA molecule. Mutalik et al. (2012)
produced a model that could predict RNA-IN/RNA-OUT binding
specificity, enabling the creation of a library of effective orthogo-
nal regulatory RNA pairs [6]. The relative ease of predicting RNA
structure means it has also been possible to use rational design to
produce other riboregulators [36] including those based on
aptamers carrying non-coding RNA fusions [37], though most638 www.elsevier.com/locate/nbtriboswitch engineering efforts require high throughput selection
and screening [38].
Protein signalling
Information flow based on protein–protein interactions can be
very rapid and efficient [39,40]. The binding of protein partners
may repress the output of one, as in the HrpRS–HrpV interaction
[22], or a signal may be passed on via a catalytic interaction, for
example proteolysis, that activates an output protein [41]. More
recent strategies have made use of inteins, regions of a protein that
catalyse their own excision; splitting the intein region and fusing
each half to a substrate protein allows trans-splicing of the two
substrates upon reconstitution of the complete intein domain
[42], with the expression of each substrate protein analogous to
the input to an AND gate [43]. The activity of some split inteins can
be controlled using small molecule ligands [44] or protein scaffolds
[45], allowing rapid induction of catalytic activity from the recon-
stituted output protein. Further to this, spatial control over pro-
tein–protein interactions using engineered protein scaffolds
allows for the coordination of multiple signalling components,
for example in kinase cascades [46]. Signals carried as proteins can
also be modified via degradation, for example using fusions to
ligand-induced degradation domains [47]. Prindle and co-workers
used competition for protein degradation to temporally coordi-
nate expression of reporter proteins much more closely than is
possible via transcriptional control [48].
Memory
A memory element in a signal processing system is one that main-
tains its output in the absence of an input. Bistable regulation of
transcription is an example of epigenetic memory [49,50]. Two
output promoters are each repressed by a regulator expressed by
the other; in the stable state one promoter is active, and maintains
expression of the regulator that represses the other without the need
for an input signal (Fig. 2b). The output state changes only when an
input signal simulates expression from the down-regulated promot-
er to the point where it dominates. Signals can be more stably
recorded by modifying the DNA molecule itself, for example,
through the use of integrases to control the directionality of a
DNA section bounded by integrase recognition sites. Bonnet et al.
(2012) produced re-writable elements using an integrase to flip DNA
in one direction, then co-expressing an excisionase to bias the
flipping directionality to the original state (Fig. 1d) [51]. Further
studies using two integrases demonstrated how the direction of a
DNA segment can be controlled in an analogous manner to various
two-input logic gates, depending on the arrangement of integrase
recognition sites and the genetic elements contained within them
[52,53]. Both bistable transcription- and integrase-based memory
systems exhibit digital output signal characteristics.
Applications of cell signal processing circuits
Biomedicine and diagnostics
Therapies that act by selectively killing diseased cells require a clear
decision to be made. This was reflected in the choice of a digital-
logic-based decision circuit by Xie et al. for their HeLa cell classifier
[16]. Once transfected into human cells the system checks for a
HeLa miRNA fingerprint, defined by three high- and three low-
abundance miRNAs that were predicted to be able to discriminate
New Biotechnology Volume 32, Number 6 December 2015 REVIEW
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FIGURE 2
Biotechnological applications of designer cell signal processing circuits. (a) A high-abundance miRNA sensing module with feed-forward motif, part of the cell-
classifier built by Xie et al. (2011) [16]. In the absence of the high-abundance miRNA (miR-hi), the reverse tetracycline transactivator (rtTA) drives expression of both
LacI and miR-44F, which both block output expression. Presence of miR-hi blocks expression of rtTA, LacI, and miR-44F to de-repress output expression. (b) Bistable
switch for memory of anhydrotetracycline (aTc) exposure [55]. A ‘trigger’ circuit (red interaction lines) produces the Cro repressor in response to aTc, as repression
of the Ptet promoter by TetR is lifted; increased Cro abundance shifts the balance of the cI/Cro bistable memory element (black interaction lines) so that
transcription of cro and the output lacZ is persistently activated. The initial state of cI repression of cro/lacZ transcription is indicated with a dashed line. (c) Tunable
transcriptional amplifier based on the hrp s54-dependent activators and inhibitors [22]. A weak transcriptional input signal is used to drive expression of HrpRS,
which combine to activate transcription from the strong PhrpL promoter. Gain is controlled through expression of HrpV, which negatively regulates PhrpL activation
by sequestering HrpS. (d) Dynamic control of fatty acid ethyl ester production (indicated by black arrows) was achieved by Zhang et al. (2012) by placing modules
for ethanol production and fatty acid consumption under the control of synthetic FadR-regulated promoters [65]. Repression by FadR (full red lines) is relieved in
response to fatty acyl-CoA (and to a lesser degree free fatty acid) ligand binding (dashed red lines).
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positive identification as a HeLa cell results in the decision to
express the output protein – either an mRFP fluorescent reporter or
the apoptosis-inducing hBax protein. The complete classifier sys-
tem contains multiple layers of decision making, but here we will
highlight features of the HeLa-high-abundance detection subunit.
This subunit takes in three miRNA inputs, and outputs tran-
scription of both lacI and a synthetic miRNA (miR-FF4) that go on
to synergistically co-regulate the ultimate output (hBax/mRFP);
the presence of the three HeLa-high-abundance miRNAs represses
transcription of lacI/miR-FF4. Rather than having the input miR-
NAs directly control LacI/miR-FF4 expression, additional motifs
were introduced to improve the signal fidelity – important when-
ever further signal processing is required, and especially so herewhen the decision is to apoptose or not. Xie et al. improved the
ON:OFF ratio by introducing feed-forward into the transcription of
lacI/miR-44F (Fig. 2a) with the rtTA activator and allowing the
input miRNAs to repress both rtTA and LacI, thus presumably
stabilising the repression of lacI/miR-44F by slowing the stochastic
re-activation of their transcription [54]. The use of two repressors
(LacI plus miR-FF4) to target the ultimate output also improves the
ON:OFF ratio by effectively lowering the rate of transcription in
the OFF state (reducing leakiness).
At the level of controlling ultimate output expression the deci-
sion logic is that of a multi-input NOR gate: the HeLa-low-abun-
dance miRNAs and the LacI/miR-FF4 output from the HeLa-high-
abundance miRNA sensing subunit must all be ‘OFF’ for the
ultimate output to be ‘ON’. The authors have noted that a realwww.elsevier.com/locate/nbt 639
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benefit from a ‘check’ function that would highlight cells classified
as cancerous using a reporter, before apoptosis is triggered with a
chemical stimulus.
Consideration of real-world applicability was central to the
demonstration by Kotula et al. (2014) of engineered gut bacteria
programmed to sense and record the presence of tetracycline [55].
A simple bistable switch based on the well-defined lambda phage
cI/Cro system was adapted so that a 100 ng ml1 dose of anhy-
drotetracycline (aTc) could perturb the system from OFF (cI-high)
to ON (Cro-high, LacZ reporter expression from PRM promoter
active) (Fig. 2b). Escherichia coli cells hosting the sensing and
memory system were introduced into the intestinal tract of living
mice, where they were able to detect aTc and remain in the
triggered state for at least five days, whilst aTc was cleared after
only eight hours. A significant feature of the study in terms of
practical applicability was the isolation of, and incorporation of
the genetic circuit into, a murine-gut-adapted E. coli strain. Whilst
lab-adapted E. coli were essentially outcompeted by gut flora by
eight days, the gut-adapted strain was still present at approxi-
mately 1000 CFU ml1. Throughout the report Kotula et al. con-
sider the burden of their system on the host – be it the effect of the
genetic programme on E. coli fitness, or the engineered strain on
the host mouse. The authors deliberately chose the cI/Cro system
because of its low demand on the host machinery (order of 102 cI/
Cro molecules per cell), and indeed no detriment to engineered E.
coli growth rate was observed in competition assays. At the next
level up, carrying the reporter strain had no effect on host mouse
fitness as assessed by monitoring host weight. This system could
be easily adapted from a diagnostic to a treatment technology by
changing the input to a sensor for pathogens or disease biomark-
ers and altering the output to an appropriate therapeutic response
[56].
Environmental sensing and remediation
Cell signal processing circuits are ideally suited to enhance the
sensitivity, specificity and robustness of cell-based biosensors for
detecting environment contaminants and hazards in a cost effec-
tive and environmental friendly manner [1,57]. Whole-cell bio-
sensors have been the subject of much research prior to the
synthetic biology movement [58], but innovative approaches
are now being applied to the topic: the use of components that
are orthogonal to (or even escape from [59]) the possibly con-
founding context of the host metabolism improves sensor accu-
racy and robustness, as does the integration of sensors with
increasingly complex synthetic signal processing circuits. For
instance, digital logic is very useful in applications where detec-
tion of threshold ligand concentrations is important, and dis-
crimination between various inputs is required. Metal ion
detection for bioremediation technologies is one such applica-
tion. Wang et al. (2013) characterised the dose–response of vari-
ous metal sensing modules in an E. coli host strain, using the
orthogonal HrpRS activator proteins as an AND gate [57]. This
modular system can be tuned by adjusting RBS sequence strength
upstream of hrpR/S gene, allowing composition of transcriptional
signals of differing strengths from various sensors. The AND gate
configuration was employed to greatly improve the selectivity of
Zn2+ sensing, using two modules that were co-activated by one of640 www.elsevier.com/locate/nbtPb2+ or Cd2+. An input signal to the AND gate can also be inverted
by linking it to HrpV (an antagonist of HrpRS activation) expres-
sion [7], thereby allowing detection systems to be built that
require the absence of one input to trigger the output. Further
refinement of the ArsR/ParsR-based arsenic sensing system via
tuning the intracelluar ArsR receptor density has pushed the
detection sensitivity below the 10 ppb level set for drinking water
by the World Health Organisation [60], making biological detec-
tion of arsenic applicable to ‘real-world’ scenarios. Further gains
in the detection limit might be achievable by increasing intracel-
lular arsenic levels using importer proteins [61].
The transcriptional output from the ParsR promoter in response
to arsenic is relatively weak; the hypersensitive HrpRS protein
complex can also be used as an analogue transcriptional amplifier
by simply relaying the signal to the stronger PhrpL promoter [7,22].
Maximum transcriptional output is fixed to the strength of PhrpL,
but different gain characteristics when the transcriptional input is
non-saturating can be realised by modifying the RBS strength
upstream of hrpR/S. If we consider the scenario where a digital
output from the arsenic sensor is required, the effect of the
amplifier is to alter the arsenic concentration that activates the
sensor output. Tuneable modulation of the activating and ampli-
fying effects of HrpRS can also be achieved, through controlled
HrpV expression (Fig. 2c). The negative influence of HrpV on PhrpL
output allows the linear output response range of the amplifier to
be shifted, and has applications where impedance matching be-
tween the sensor and downstream modules is required, or when
prototyping the amplifier with new sensor inputs. Furthermore,
connection of the amplifier output (PhrpL) to the gain-control input
(hrpV) would create a negative feedback loop for robust adaptive
control of output response.
Bioprocessing control and optimisation
Applying the paradigm of dynamic analogue control of gene
expression to designed biosynthetic pathways will be essential if
optimal performance is to be maintained in response to changes in
environment and chemical concentrations – especially the con-
centration of pathway intermediates. Factors such as pH, oxygen
concentration, and nutrient availability can all be linked to repor-
ters to provide information about the state of the system, allowing
the culturing system to compensate for stress via a detection,
analysis and actuation loop [62]. Whilst external systems are
arguably necessary for some ‘high-level’ factors such as culture
pH, faster and more precise control is desirable at the level of
enzyme concentration in biosynthetic pathways [63]. For exam-
ple, Fung and co-workers demonstrated the integration of a syn-
thetic regulatory network with host metabolism, using a
transcriptional oscillator to control and report on glycolytic flux
in E. coli [64]. Two more recent studies (below) highlight the
benefits of dynamic control of gene expression over traditional
optimisation of constitutive promoters in the context of biomole-
cule synthesis applications.
A positive feed-forward signal was employed to coordinate three
modules involved in fatty acid ethyl ester (FAEE) biosynthesis [65].
FAEEs are a potential diesel fuel replacement, formed through
condensation of free fatty acid and ethanol (a toxic intermediate).
FadR senses free fatty acids, disassociating from its 17 bp regulator
region within a promoter upon ligand binding to allow RNA
New Biotechnology Volume 32, Number 6 December 2015 REVIEW
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were built based on the phage lambda and T7 promoters in order
to increase the dynamic range (to allow for higher flux in the
engineer strain) compared to weaker native FadR-responsive pro-
moters, and after validation were further modified to contain a lacI
binding site to allow for external control using IPTG. Genes coding
for both ethanol production and FAEE condensation enzymes
were then placed under the control of combinations of the syn-
thetic FadR/LacI-responsive promoters, ensuring ethanol was only
produced if fatty acid was also available for the condensation
reaction, and that fatty-acid CoA-acylation and subsequent esteri-
fication were coordinated for efficient use of CoA (Fig. 2d). A three-
fold improvement in FAEE yield over the previous best strain was
achieved due to the more effective flux balance through the
system.
The engineered mevalonate-based pathway for biosynthesis of
the toxic isoprenoid farnesyl pyrophosphate (FPP) is linear, mak-
ing control of toxic FPP accumulation a case of applying both
negative feed-back to the FPP synthesis pathway, and positive feed-
forward to any downstream FPP consuming enzymes [66]. In the
absence of previously identified FPP-responsive elements, the E.
coli transcriptome was analysed for FPP-responsive promoters. A
library of 35 was chosen and screened for the ability to control
production of the FPP-derivative amorphadiene. The highest yield
using the FPP-responsive promoters resulted from a combination
that weakly up-regulated FPP consumption, and weakly down-
regulated FPP production. Despite being negatively regulated by
FPP concentration, FPP biosynthesis enzymes were produced in
higher amounts compared to conditions where expressed from an
inducible promoter. Whilst further improvements are possible –
some results indicated that higher levels of amorphadiene
synthase expression would be beneficial – it was demonstrated
that yields were at least 2-fold higher from the strain that self-
regulated FPP production compared to those that used inducible/
constitutive promoters.
In both examples it was shown that the dynamic response was
the key to achieving optimal yield, rather than simply that the
pathway enzymes had been tuned to optimal levels; combina-
tions of both stronger and weaker constitutive promoters were
less effective. Both studies also showed the dynamically-respon-
sive strains excreted less acetate, implying beneficial effects of
improved regulation extend to central metabolic flux. Reviewing
their work, the authors look forward to the prospect of much
faster post-translational control over metabolic pathways using
allosterically regulated enzymes that may be designed de novo
[63].
Challenges and outlook
The prototype applications described above highlight the great
potential of synthetic cell signal processing circuits, but they
remain prototypes simply because the creation of new biological
functions is not fully an engineering exercise. Though resources of
characterised parts are growing, there is not enough information
available to generate accurate predictions of the performance of
complex synthetic system activities in living organisms. Expand-
ing the range of available orthogonal genetic components remains
a key foundational challenge, as there are insufficient orthogonal
elements in the current toolkit to design large synthetic biologicalsystems, especially where digital signal processing is used to obtain
clear input–output relationships [1]. Digital logic is part-heavy [67]
and will encounter problems with scale-up due to the presently
limited number of available orthogonal parts and the unpredict-
able consequences of composing multiple genetic modules. Ana-
logue computing is an attractive alternative strategy for producing
high order functions (e.g. linear amplification, addition) without
employing a large amount of orthogonal parts. It will be necessary
to combine both digital and analogue computing in future ad-
vanced signal processing circuits to achieve complex cellular
functions, and this requires the development of more part librar-
ies. It is encouraging to observe investigations into new
approaches to the engineering of orthogonal regulatory circuit
components, such as using splicing protein inteins [43] or CRISPR-
Cas9 tools [27], that are highly anticipated to expand the synthetic
biologist’s tool kit.
Beyond the characteristics of parts themselves, we are just
beginning to appreciate the mechanisms behind contextual vari-
ance observed in synthetic circuits that gives rise to a large part of
their unpredictable behaviour [5,68]. Cardinale and Arkin [69]
reviewed three levels of context dependency for synthetic sys-
tems: (i) composition – how elements of the system interact; (ii)
host – how the system interacts with the cellular machinery; (iii)
environment – the influence of external physical and chemical
factors, and other organisms. Strategies to measure context de-
pendency are being developed [9,68], and management of some
of the interactions is possible: post-transcriptional cleavage of
mRNAs, for example, improves translational consistency [35]; use
of orthogonal parts [8], dynamic control of pathway flux [65], and
use of DNA-based rather than epigenetic memory [51] all mini-
mise interactions with, and the load on, the host machinery.
Contextual variance may be significantly reduced through the use
of artificial chassis for synthetic gene networks, if the loss of
auxiliary biological functions (i.e. anabolic metabolism, ATP
production, etc.) is acceptable for the application. Artificial lipo-
somes can be produced with precisely defined contents [70], and
recently paper-based systems have been demonstrated as an
inexpensive platform for both rapid prototyping and clinical
testing [59].
With regard to future implementation, minimising the context
dependency of synthetic systems is one way of making them more
robust, as there is selection pressure against synthetic systems that
cause stress to the host. Depending on the lifetime of the biological
device, engineering reduced evolution rates for specific compo-
nents or the entire host may be required [71]. Robustness as a
general feature of designed systems describes the ability to main-
tain performance in the face of a changing environment. As more
complex systems are designed, robustness can be incorporated by
using dynamic control mechanisms and adding redundancy to
pathways [72].
Beyond the issues surrounding the construction and effective-
ness of designer biological systems, real-world deployment of
these devices requires them to be safe, and ethically and legally
compliant [73,74]. Many safety features can be engineered into
[75] synthetic systems, but it is not purely a design problem – the
field must continue to foster an open, responsible culture that
inspires trust from the public. These issues will be solved in
concert: as the behaviour of synthetic biological devices becomeswww.elsevier.com/locate/nbt 641
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eviewmore predictable and robust, so they become safer. Similarly,
repeated demonstrations of the reliability and efficacy of such
systems will hopefully improve or maintain public perception of
designer biotechnology. Consequently, a cautious, transparent
and responsive approach is required for synthetic biological sys-
tems to graduate from the lab.642 www.elsevier.com/locate/nbtAcknowledgements
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